KENNETH FERRERA: Open Payments
NPI 1164899241 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,488 in 160 payments from 19 companies in 2025. Trend: 2023 $1,053 · 2024 $2,394 · 2025 $2,488
Food & beverage: $2,344Education: $144
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 47 | $473 |
| UCB, Inc. | 28 | $420 |
| GENZYME CORPORATION | 12 | $315 |
| Organon LLC | 12 | $299 |
| ABBVIE INC. | 19 | $254 |
| E.R. Squibb & Sons, L.L.C. | 19 | $189 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $98 |
| Lilly USA, LLC | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| SANOFI-AVENTIS U.S. LLC | 1 | $49 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Sotyktu, RINVOQ, VTAMA, SKYRIZI, ILUMYA.
Industry payments across MD — which companies pay providers there.
